A study with 50 U.S. hematologists reveals that approximately one-third have already prescribed Adakveo or Oxbryta Newton, MA., September 30, 2020 — Sickle cell disease (SCD) is a chronic, [...]
Young adulthood is one of the most exciting times in life. It is full of new experiences, challenges, freedoms, and responsibilities. Young adults living with a chronic medical condition have [...]
In the midst of the COVID-19 pandemic, sickle cell disease patients, their caregivers, and their physicians are challenged to find ways to avoid hospital visits, manage acute pain crises at [...]
Investment in R&D is set to deliver much-needed, potentially disease-modifying therapies for people with sickle cell disease (SCD), especially those with severe disease. Severe disease is characterized by frequent [...]
The last six months have delivered a wave of clinical, commercial, and regulatory developments regarding the treatment of sickle cell disease (SCD). Indeed, the U.S. launch of two new [...]